BeOne Medicines ONC
NASDAQ ONC
$359.97 -5.03 (-1.38%)
At close: Sep 24, 2026 · 4:00 PM EDT

BeOne Medicines (ONC) Other financing activities (2016 - 2026)

BeOne Medicines' (ONC) quarterly Other financing activities came in at $11.0 million in Q2 2026, down 66.67% year-over-year from $33.1 million in Q2 2025, and down 53.73% quarter-over-quarter from $23.9 million in Q1 2026.

Analysis

BeOne Medicines (ONC) Other financing activities (2016 - 2026) Analysis & Trends

BeOne Medicines (ONC) has reported Other financing activities for 11 consecutive years, with $11.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other financing activities fell 66.67% year-over-year to $11.0 million in Q2 2026; TTM through Jun 2026 was $134.7 million, a 10.85% increase from a year earlier, with the FY2025 full-year figure at $196.3 million, up 332.59% from the prior year.
  • Other financing activities was $11.0 million for Q2 2026 at BeOne Medicines, down from $23.9 million in the prior quarter.
  • Over five years, Other financing activities peaked at $80.5 million in Q3 2025 and troughed at $3.4 million in Q4 2023.
  • A 5-year average of $21.1 million and a median of $15.5 million in 2024 frame the typical range for Other financing activities.
  • Across the five-year window, Other financing activities sank 99.66% in 2022 and soared 495.69% in 2025, its largest moves.
  • Over 5 years, Other financing activities stood at $11.3 million in 2022, then tumbled by 70.23% to $3.4 million in 2023, then surged by 161.76% to $8.8 million in 2024, then jumped by 118.79% to $19.2 million in 2025, then sank by 42.59% to $11.0 million in 2026.
  • The last three Other financing activities figures came in at $11.0 million (Q2 2026), $23.9 million (Q1 2026), and $19.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 BeOne Medicines 41.25 Bn 36.15 Bn 1.53 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.05 Mn
Mar 31, 2026 23.88 Mn
Dec 31, 2025 19.24 Mn
Sep 30, 2025 80.54 Mn
Jun 30, 2025 33.14 Mn
Mar 31, 2025 63.36 Mn
Dec 31, 2024 8.80 Mn
Sep 30, 2024 16.22 Mn
Jun 30, 2024 5.56 Mn
Mar 31, 2024 14.79 Mn
Dec 31, 2023 3.36 Mn
Sep 30, 2023 17.18 Mn
Jun 30, 2023 3.58 Mn
Mar 31, 2023 31.59 Mn
Dec 31, 2022 11.29 Mn
Sep 30, 2022 16.71 Mn
Jun 30, 2022 7.09 Mn
Mar 31, 2022 11.88 Mn
Dec 31, 2021 3.31 Bn
Sep 30, 2021 46.59 Mn
API Access

BeOne Medicines Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ONC&period=max&api_key=YOUR_API_KEY